ConductScience.org, home

Paper28523352

Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.

Henderson S and 7 others. Eur Radiol, 2017. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer. Papers, record 28523352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28523352

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
PubMed
Journal
Eur Radiol
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.08
iCite
Revised in PubMed
2024-07-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Henderson SShelley
2Purdie CColin
3Michie CCaroline
4Evans AAndrew
5Lerski RRichard
6Johnston MMarilyn
7Vinnicombe SSarah
8Thompson AMAlastair M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
BreastMajor topic
Breast NeoplasmsMajor topic
Magnetic Resonance ImagingMajor topic
Adult
Aged
Female
Humans
Middle Aged
Neoadjuvant Therapy
ROC Curve
Retrospective Studies

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122086561Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.Eur Radiol2012https://conductscience.org/library/papers/22086561PubMed
223436342
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017.
Cancer2013https://conductscience.org/library/papers/23436342PubMed
310542352Texture analysis of spinal cord pathology in multiple sclerosis.Magn Reson Med1999https://conductscience.org/library/papers/10542352PubMed
415908529MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.AJR Am J Roentgenol2005https://conductscience.org/library/papers/15908529PubMed
526663695Breast MRI radiogenomics: Current status and research implications.J Magn Reson Imaging2016https://conductscience.org/library/papers/26663695PubMed
617785706Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.J Clin Oncol2007https://conductscience.org/library/papers/17785706PubMed
79400844Multifeature analysis of Gd-enhanced MR images of breast lesions.J Magn Reson Imaging1997https://conductscience.org/library/papers/9400844PubMed
821220595Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.J Clin Oncol2011https://conductscience.org/library/papers/21220595PubMed
919945302Characterization of breast cancer types by texture analysis of magnetic resonance images.Acad Radiol2010https://conductscience.org/library/papers/19945302PubMed
1024840393Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.NMR Biomed2014https://conductscience.org/library/papers/24840393PubMed
1122623692Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.Radiology2012https://conductscience.org/library/papers/22623692PubMed
1222034451Texture analysis of the brain: from animal models to human applications.Dialogues Clin Neurosci2004https://conductscience.org/library/papers/22034451PubMed
1323093486Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Insights Imaging2012https://conductscience.org/library/papers/23093486PubMed
1422198468Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).Breast Cancer Res Treat2012https://conductscience.org/library/papers/22198468PubMed
1526971432Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters.Eur J Radiol2016https://conductscience.org/library/papers/26971432PubMed
1624529560Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.Lancet2014https://conductscience.org/library/papers/24529560PubMed
1715556588Texture analysis of medical images.Clin Radiol2004https://conductscience.org/library/papers/15556588PubMed
1814673041Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?J Clin Oncol2003https://conductscience.org/library/papers/14673041PubMed
1919440188I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.Clin Pharmacol Ther2009https://conductscience.org/library/papers/19440188PubMed
2026243303Texture analysis on MR images helps predicting non-response to NAC in breast cancer.BMC Cancer2015https://conductscience.org/library/papers/26243303PubMed

See all 42 referencesDownload CSV of references

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42225584Refining the Predictive Role of T2-Weighted Imaging Features in Breast Cancer: A Hypothesis Linking Tumor Characteristics to Extreme Chemoresistance.Korean J Radiol2026https://conductscience.org/library/papers/42225584PubMed
41030906Multimodal Magnetic Resonance Imaging and Radiomics in Brucella Spondylitis: Diagnostic Applications and Differential Diagnosis.J Multidiscip Healthc2025https://conductscience.org/library/papers/41030906PubMed
37835774Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features.Diagnostics (Basel)2023https://conductscience.org/library/papers/37835774PubMed
37534540The use of radiomics in magnetic resonance imaging for the pre-treatment characterisation of breast cancers: A scoping review.J Med Radiat Sci2023https://conductscience.org/library/papers/37534540PubMed
36831368Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI.Cancers (Basel)2023https://conductscience.org/library/papers/36831368PubMed
36802982Radiomic analysis in contrast-enhanced mammography using a multivendor data set: accuracy of models according to segmentation techniques.Br J Radiol2023https://conductscience.org/library/papers/36802982PubMed
36418622Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.Eur Radiol2023https://conductscience.org/library/papers/36418622PubMed
36414984
An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study.
Breast Cancer Res2022https://conductscience.org/library/papers/36414984PubMed
36202934Robustness of radiomics to variations in segmentation methods in multimodal brain MRI.Sci Rep2022https://conductscience.org/library/papers/36202934PubMed
36006071Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI.Tomography2022https://conductscience.org/library/papers/36006071PubMed
35884576Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.Cancers (Basel)2022https://conductscience.org/library/papers/35884576PubMed
35849178Changes in kinetic heterogeneity of breast cancer via computer-aided diagnosis on MRI predict the pathological response to neoadjuvant systemic therapy.Eur Radiol2023https://conductscience.org/library/papers/35849178PubMed
35314626Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI.Tomography2022https://conductscience.org/library/papers/35314626PubMed
34858821The Potential Value of Texture Analysis Based on Dynamic Contrast-Enhanced MR Images in the Grading of Breast Phyllode Tumors.Front Oncol2021https://conductscience.org/library/papers/34858821PubMed
34829433Radiomics Analysis of Multi-Phase DCE-MRI in Predicting Tumor Response to Neoadjuvant Therapy in Breast Cancer.Diagnostics (Basel)2021https://conductscience.org/library/papers/34829433PubMed
34826254Association between breast cancer's prognostic factors and 3D textural features of non-contrast-enhanced T1 weighted breast MRI.Br J Radiol2022https://conductscience.org/library/papers/34826254PubMed
34704213Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence.Radiol Med2022https://conductscience.org/library/papers/34704213PubMed
34671399Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms.J Oncol2021https://conductscience.org/library/papers/34671399PubMed
34503081Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.Cancers (Basel)2021https://conductscience.org/library/papers/34503081PubMed
34262646MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.Oncotarget2021https://conductscience.org/library/papers/34262646PubMed

See all 40 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CLEC3B7123PubTator's text mininghttps://conductscience.org/library/genes/7123NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28523352

GET https://conductscience.org/api/papers/v1/28523352/references?page=2